Pharmaceutical Chemical Raw Powder CAS 118288-08-7 Lafutidine

Category:Intermediates > Pharmaceutical Intermediates
Product Name:Pharmaceutical Chemical Raw Powder CAS 118288-08-7 Lafutidine
CAS No.:118288-08-7
Standard:In-house Standards
Price(USD):US$50~US$200/Kg
Company:SCM Pioneering Co.,Ltd

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Shandong, China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: 10000kg

    Contract Manufacturing: CRO,CMO

    Packaging Information: 1kg/barrel

  • Delivery Lead Time: 15-50days

    Sample Provided: yes

    Payment Terms: T/T

    Specification of Analysis

    Product Name Lafutidine Powder
    CAS 118288-08-7
    Appearance white powder
    Molecular formula C22H29N3O4S
    Molecular Weight 431.55
    Assay 98%
    Shelf Life Two years
    Storage Store in a dry, cool and sealed place

    What is Lafutidine?

    Lafutidine (INN) is a second generation H2 receptor antagonist having multimodal mechanism of action. It is currently marketed in Japan (Stogar) China (Lemeiting) and India (Lafaxid) It not only suppresses gastric acid secretion, but also has cytoprotective properties by the virtue of its property to induce the collagen synthesis in the gastric mucosa. It has a novel mechanism of action in addition to blocking the H2 receptors, it decreases inflammation by modulating calcitonin gene-related peptide (CGRP) and vanilloid receptors It is also found to stimulate mucin biosynthesis and promote the restitution of damaged mucosa.

    Function and Application of Lafutidine

    Lafutidine (INN) is a second generation H2 receptor antagonist having multimodal mechanism of action.
    It is currently marketed in Japan (Stogar) China (Lemeiting) and India (Lafaxid) It not only suppresses gastric
    acid secretion, but also has cytoprotective properties by the virtue of its property to induce the collagen
    synthesis in the gastric mucosa. It has a novel mechanism of action in addition to blocking the H2 receptors,
    it decreases inflammation by modulating calcitonin gene-related peptide (CGRP) and vanilloid receptors It
    is also found to stimulate mucin biosynthesis and promote the restitution of damaged mucosa.

Send your message to this supplier
  • From:
  • To:
    SCM Pioneering Co.,Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service